Mehrotra Parth 4
4 · Privia Health Group, Inc. · Filed Mar 12, 2026
Research Summary
AI-generated summary of this filing
Privia Health (PRVA) CEO Parth Mehrotra Sells Shares, Receives Awards
What Happened Parth Mehrotra, CEO of Privia Health Group, sold 21,097 shares in an open-market transaction on 2026-03-10 for total proceeds of approximately $479,113 (weighted average price $22.71). Around the same time he was credited with awards/vesting of a total of 313,246 shares: 141,342 restricted stock units (RSUs) granted 2026-03-10 and 171,904 shares distributed upon vesting of performance stock units (PSUs) on 2026-03-11. The sale is a disposal (not a purchase); the awards are compensation/vesting events (no cash paid).
Key Details
- Sale: 21,097 shares on 2026-03-10; weighted average price $22.71; prices ranged $22.27–$23.23; total proceeds ≈ $479,113. (Footnote F2)
- Awards/Vesting: 141,342 RSUs granted 2026-03-10 (vest in substantially equal annual installments; F3) and 171,904 shares distributed 2026-03-11 reflecting vested PSUs from prior grants (F4). Total awarded/vested: 313,246 shares.
- Sale executed under a pre-arranged Rule 10b5-1 trading plan (Footnote F1).
- Shares owned after these transactions are not specified in the provided excerpt of the filing.
- Filing date: 2026-03-12 for transactions on 2026-03-10 and 2026-03-11 — filing appears timely.
Context Sales made under a 10b5-1 plan are pre-arranged and often routine; they do not necessarily signal a change in insider view. The RSUs are subject to time-based vesting, while the PSUs reflect performance-based vesting for the 2023–2025 period. For investors, outright purchases are generally a stronger bullish signal than sales or routine compensation-related awards.
Insider Transaction Report
- Sale
Common Stock, $0.01 par value per share
[F1][F2]2026-03-10$22.71/sh−21,097$479,113→ 322,698 total - Award
Common Stock, $0.01 par value per share
[F3]2026-03-10+141,342→ 464,040 total - Award
Common Stock, $0.01 par value per share
[F4]2026-03-11+171,904→ 635,944 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person .
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.27 to $23.23 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
- [F4]Vesting and distribution to reporting person of 141,948 shares underlying performance stock units that were granted on May 9, 2023, and 29,956 shares underlying performance stock units that were granted on July 1, 2023, in both cases for the performance period 2023-2025.